Literature DB >> 29560523

Eltrombopag as initial monotherapy for severe aplastic anemia-a case report.

George M Rodgers1, Jeffrey A Gilreath2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29560523     DOI： 10.1007/s00277-018-3303-z

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  2 in total

1.  Eltrombopag combined with cyclosporine may have an effect on very severe aplastic anemia.

Authors:  Hai Cheng; Xue Wang; Dian Zhou; Jiang Cao; Andre Larochelle; Kai-Lin Xu
Journal:  Ann Hematol       Date:  2019-03-20       Impact factor: 3.673

2.  Relationship between CYP2C8, UGT1A1, and ABCG2 gene polymorphisms and the exposure, efficacy, and toxicity of eltrombopag in the treatment of refractory aplastic anemia.

Authors:  Wei Zuo; Bo Liu; Miao Chen; Bo Zhang; Bing Han
Journal:  Eur J Clin Pharmacol       Date:  2022-08-03       Impact factor: 3.064
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.